UFC fighter Abu Azaitar was given a seven-month suspension by the U.S. Anti-Doping Agency on Monday due to a positive test for tamoxifen. The suspension took effect on August 25th of 2020.
The suspension for Azaitar was a reduced version than the amount of sanctions that USADA were eligible to place. The reduced sentence was given due to “specific circumstances of his [Azaitar] case and for his Full and Complete Cooperation,” per a statement from USADA.
USADA’s statement says Azaitar claimed he was prescribed tamoxifen by a physician, although he did not have a “Therapeutic Use Exemption,” a type of exemption USADA allows for medications if prescribed to an athlete.
Azaitar last competed in 2018, where he won his UFC debut against Vitor Miranda.
Azaitar was booked against Alessio Di Chirico and Joaquin Buckley in 2020 prior to withdrawing from both bouts.